Biofrontera Inc. has been notified by The Nasdaq Stock Market of its failure to meet the continued listing requirement under Nasdaq Listing Rule 5550(b)(1). As of May 21, 2025, the company's stockholders' equity was reported at $469,000, falling short of the minimum $2,500,000 requirement. Additionally, Biofrontera did not satisfy alternative criteria including a $35 million market value of listed securities or a net income of $500,000. The notice does not immediately affect trading of Biofrontera's securities. The company has 45 days to submit a compliance plan and, if accepted, could have up to 180 days to meet the requirements. If the plan is rejected, Biofrontera can appeal to a Nasdaq Hearings Panel.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。